Aceatherapeutics
1 known investors
Find your way into Aceatherapeutics
Sign up to find every way you can get introduced to Aceatherapeutics
- Your email: who you already know at Aceatherapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Aceatherapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
ACEA Therapeutics is a clinical-stage pharmaceutical company developing small molecule inhibitors, antibody drug conjugates, and cell therapies to address unmet needs in cancer, autoimmune disease, and COVID-19. The company operates manufacturing and commercial capabilities in China and has multiple candidates in clinical development.
Investors · 1
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Aceatherapeutics do?
- ACEA Therapeutics is a clinical-stage pharmaceutical company developing small molecule inhibitors, antibody drug conjugates, and cell therapies to address unmet needs in cancer, autoimmune disease, and COVID-19. The company operates manufacturing and commercial capabilities in China and has multiple candidates in clinical development.
- Who are Aceatherapeutics's investors?
- Aceatherapeutics's investors include Qiming Venture Partners.
